Newer Drug Kisqali (ribociclib) Extends Lives of Young Breast Cancer Patients
SATURDAY, June 1, 2019 -- Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found.
The drug, called Kisqali (ribociclib), is already approved for treating such patients...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Hormonal Therapy | Hormones | Women